EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Nationwide Analysis of the Phenotype/Genotype Landscape of Hemophagocytic Lymphohistiocytosis: UNC13D Associates with Poor Prognosis

Dafna Brik Simon, Yarden Greental Ness, Orly Dgany, Sharon Noy-Lotan iD, Tanya Krasnov, Galit Berger, Tamar Feuerstein, Jerry Stein, Aviva Kraus, Asaf Yanir, Assaf Barg iD, Elad Jacoby iD und 7 weitere

Genes · 2025

DOI: 10.3390/genes16111315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Dafna Brik Simon und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva 4920235, Israel. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Membrane Proteins. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/objectives: Geographic and ethnic differences influence the genetic landscape of hemophagocytic lymphohistiocytosis (HLH) and the frequency of familial HLH (FHL); this in turn can affect outcomes.

Methods

We collected data on 98 patients treated for HLH between 1 January 2001 and 31 July 2024 at four tertiary centers, characterizing the genotype/phenotype correlations.

Results

Half of the patients, 51 (52%), were symptomatic by age 1 year and 43 (44%) were diagnosed by that age. Our varied population included 43% Sephardic/Ashkenazi/Ethiopian Jews, 50% Muslim Arabs, and 7% Druze. Molecular analysis was performed on 90.5% of patients and revealed an FHL-related variant in 72%. The genetic variation included biallelic variants in PRF1 (21), UNC13D (12), STXBP2 (15), and STX (1). Eight hemizygous variants were found in X-linked lymphoproliferative disorder-related genes. A RAB27A monoallelic variant in an infant with a severe phenotype was considered pathogenic. The recently described HLH-related gene, ZNFX1, was mutated with varying penetrance in three symptomatic siblings. Overall, of the 94/98 with follow-up, 77% are alive. Strikingly, 5/12 (41.6%) patients with UNC13D variants died while 14/15 (93.3%) patients with STXBP2 variants survived. Logistic regression found poor prognosis associated with young age at diagnosis (p < 0.001), any variant (p = 0.016), UNC13D variant (p < 0.001), poor initial treatment response (p = 0.009), and no BMT (p = 0.005).

Conclusions

Our cohort included an extremely high rate of genetic testing and detection of FHL-related variants. UNC13D variations are associated with exceedingly poor outcomes. Response to initial treatment seems crucial for positive outcomes, as does access to hematopoietic stem cell transplantation. Overall, we report a high survival rate, possibly due to a high index of suspicion and prompt diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticMembrane ProteinsHumansFemaleMaleInfantChild, PreschoolChildPrognosisPhenotypeAdolescentrab27 GTP-Binding ProteinsMunc18 ProteinsMutationPerforinAdultGenotypeGenetic Association StudiesInfant, Newborn

Stichwörter der Autor:innen

familial HLHgenotype/phenotype associationgermline diseasehemophagocytic lymphohistiocytosis

Substanzen

UNC13D protein, humanMembrane ProteinsPRF1 protein, humanrab27 GTP-Binding ProteinsMunc18 ProteinsPerforinRAB27A protein, humanSTXBP2 protein, human

Autor:innen und Institutionen

  • Department of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva 4920235, Israel.
  • Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 39040, Israel.
  • Pediatrics Department, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan 52621, Israel.
  • Felsenstein Medical Research Center, Petah Tikva 4920235, Israel.
  • Hematology-Oncology Division Safra Children Hospital, Sheba Medical Center, Ramat-Gan 52621, Israel.
  • Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa 3109601, Israel.

ORCID-Profile: Sharon Noy-Lotan, Assaf Barg, Elad Jacoby, Ehud Even-Or, Orna Steinberg-Shemer

Zitieren

APA

Brik Simon, D., Greental Ness, Y., Dgany, O., Noy-Lotan, S., Krasnov, T., Berger, G., Feuerstein, T., Stein, J., Kraus, A., Yanir, A., Barg, A., Jacoby, E., Mandel-Shorer, N., Harlev, D., Even-Or, E., Tamary, H., Gilad, O., Steinberg-Shemer, O., & Yacobovich, J. (2025). A Nationwide Analysis of the Phenotype/Genotype Landscape of Hemophagocytic Lymphohistiocytosis: UNC13D Associates with Poor Prognosis. Genes. https://doi.org/10.3390/genes16111315

Vancouver

Brik Simon D, Greental Ness Y, Dgany O, Noy-Lotan S, Krasnov T, Berger G, et al. A Nationwide Analysis of the Phenotype/Genotype Landscape of Hemophagocytic Lymphohistiocytosis: UNC13D Associates with Poor Prognosis. Genes. 2025. doi:10.3390/genes16111315

BibTeX
@article{BrikSimon2025,
  author = {Brik Simon, Dafna and Greental Ness, Yarden and Dgany, Orly and Noy-Lotan, Sharon and Krasnov, Tanya and Berger, Galit and Feuerstein, Tamar and Stein, Jerry and Kraus, Aviva and Yanir, Asaf and Barg, Assaf and Jacoby, Elad and Mandel-Shorer, Noa and Harlev, Dan and Even-Or, Ehud and Tamary, Hannah and Gilad, Oded and Steinberg-Shemer, Orna and Yacobovich, Joanne},
  title = {A Nationwide Analysis of the Phenotype/Genotype Landscape of Hemophagocytic Lymphohistiocytosis: UNC13D Associates with Poor Prognosis},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16111315}
}
Kostenlos starten →